Diseases, Conditions, Syndromes

No chemopreventive effect seen for H2RAs in barrett's esophagus

(HealthDay)—For patients with Barrett's esophagus (BE), proton pump inhibitor (PPI) but not histamine-2 receptor antagonist (H2RA) use is associated with reduced risk of neoplastic progression, according to research published ...

page 4 from 4